Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol NRAS contributors: mct - updated : 06-05-2016
HGNC name neuroblastoma RAS viral (v-ras) oncogene homolog
HGNC id 7989
DNA
TYPE functioning gene
STRUCTURE 12.44 kb     7 Exon(s)
Genomic sequence alignment details
10 Kb 5' upstream gene genomic sequence study
MAPPING cloned Y linked Y status confirmed
RNA
TRANSCRIPTS type messenger
identificationnb exonstypebpproduct
ProteinkDaAAspecific expressionYearPubmed
7 splicing 4461 - 189 - Taparowsky (1983)
- splicing 4300 - - - Taparowsky (1983)
EXPRESSION
Type ubiquitous
   expressed in (based on citations)
organ(s)
SystemOrgan level 1Organ level 2Organ level 3Organ level 4LevelPubmedSpeciesStageRna symbol
Cardiovascularheart   highly
Lymphoid/Immunelymph node   highly
Skin/Tegumentskin   highly
Urinarybladder   highly
cell lineage
cell lines
fluid/secretion
at STAGE
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
  • GTP-GDP binding sites
  • conjugated LipoP , PhosphoP
    HOMOLOGY
    interspecies homolog to murine Nras (99.5pc)
    homolog to rattus Nras (99.5pc)
    intraspecies homolog to neuroblastoma Ras viral (v-ras) oncogene
    Homologene
    FAMILY
  • GTPase superfamily
  • RAS gene family (C-Hras1 and C-Hras2)
  • CATEGORY protooncogene
    SUBCELLULAR LOCALIZATION     plasma membrane
        intracellular
    intracellular,cytoplasm,organelle,mitochondria,inner
    intracellular,cytoplasm,organelle,mitochondria,outer
    intracellular,cytoplasm,organelle,Golgi
    text
  • attached to the membrane by a lipid anchor, at internal side of plasma membrane
  • associated with both the outer membrane and inner mitochondrial compartments
  • membrane protein that shuttles between the golgi apparatus and the plasma membrane, shutlling regulated through palmitoylation and depalmitoylation (Rocks 2005)
  • basic FUNCTION
  • possessing intrinsic GTPase activity
  • has an immune regulatory function and its absence or gain-of-function affects primarily hematopoietic cells
  • having a farnesylation independent function and within the inner mitochondrial compartment being an essential component of the retrograde signaling system between the mitochondria and nucleus
  • tumor type–specific mutation spectrum of Ras genesis dictated by their regulation of expression and that the altered Ras proteins that can be palmitoylated act as particularly potent oncoproteins
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism
    signaling signal transduction
    a component
    INTERACTION
    DNA
    RNA
    small molecule nucleotide,
  • GTP binding
  • protein
  • CHMP6 and VPS4A bound to NRAS but not KRAS
  • DDX43 may promote NRAS protein expression by unwinding and stabilizing NRAS mRNA, therefore enhancing its translation
  • LZTR1 facilitates polyubiquitination and degradation of RAS-GTPases MRAS, HRAS, NRAS, and KRAS
  • cell & other
    REGULATION
    activated by a GTPase activating protein
    inhibited by a guanine nucleotide-exchange factor
    ASSOCIATED DISORDERS
    corresponding disease(s) NS6
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral somatic mutation      
    in multiple myeloma, in primary plasma cell leukemia at an early stage, and in thyroid cancer with poor prognosis
    tumoral germinal mutation     gain of function
    in autoimmune lymphoproliferative syndrome
    tumoral somatic mutation      
    in high hyperdiploid childhood acute lymphoblastic leukemia
    tumoral somatic mutation      
    in hepatocellular carcinoma
    tumoral somatic mutation      
    in primary melanocytic tumours of the CNS, GNA11 and NRAS mutations represent a mechanism of MAPK pathway activation alternative to the common GNAQ mutations( :
    Susceptibility
    Variant & Polymorphism
    Candidate gene
    Marker
    Therapy target
    ANIMAL & CELL MODELS
    effect of Nras loss on tumor development in Rb1 heterozygous mice, the loss of the protooncogene Nras in certain cellular contexts can promote malignant tumor progression (Takahashi 2006)